Annually, an alarming number of individuals in Europe, totaling over 4 million, are faced with the daunting reality of healthcare-associated infections (HAIs).

These infections, acquired within healthcare facilities, are a significant contributor to morbidity and mortality and impose a heavy burden on healthcare systems. The spread of these infections can often be attributed to breaches in hygiene practices, highlighting the critical need for improved sanitation measures on personal, domestic, and environmental levels.

The challenge is compounded by the fact that traditional alcohol-based sanitisation products, while somewhat effective, fall short in addressing the complexity and magnitude of infectious agents that pervade our communities.

Recognizing this gap, Swiss Bio Group has taken a proactive stance through the introduction and development of BioFresh, a product line that exemplifies the companies unwavering commitment to health and safety as part of the Infection control industry.

Our products are not merely commercial offerings; they are the culmination of rigorous scientific research, designed to actively reduce the presence of pathogens and harmful microorganisms that threaten our daily safety.

In the face of escalating microbial resistance, a phenomenon that diminishes the efficacy of conventional antimicrobial treatments, Swiss Bio Group acknowledges the imperative for ongoing innovation. Our efforts are channeled into developing solutions that safeguard individuals not only in their homes but also during travel and within the critical environments of medical centers.

The objective is clear: to enhance the standard of safety to the highest degree practicable, Improve Air Quality plus quality of Life wherever possible.

The nucleus of our innovation is our state-of-the-art Research Centers located in the UK and Switzerland, with all manufacturing and accreditation conducted from our UK facilities.

There is a group of dedicated teams of experts deeply engaged in the exploration of emerging threats posed by an array of microorganisms allowing us to keep on top of the ever evolving world of microbes, airborne pollutants that affect our everyday life.

These organisms, invisible to the naked eye, are formidable adversaries to human health and wellbeing.

Our world is in a perpetual state of flux, increasingly impacted by new pathogenic variants, allergens, and volatile organic compounds (VOCs) that infiltrate our air, water, and surfaces.

Swiss Bio Group stands as a vigilant guardian against these ever-increasing threats.

It is the ethos of SBG to be relentlessly forward-thinking, ensuring that our development of new protocols and our strategies for health protection are as adaptive and dynamic as the world in which we live.

As we navigate through the complex landscape of public health challenges, our commitment remains steadfast:

to deliver products and protocols that not only meet but exceed the requirements of today's health standards.